PATENT CLAIM ANALYSIS

Application Number: 15968834
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
Compositions, vaccines and methods for inducing protective immunity against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more viral expression vectors and an isolated antigenic polypeptide induced strong protective immunity against infections by one or multiple clades of HIV.

Claim (Index 7):
The method of  claim 3 , wherein the one or more rAd26 vectors encode three HIV antigenic polypeptides having the amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 3 and SEQ ID NO: 4; the immunogenically effective amount of the isolated HIV envelope polypeptide comprises a stabilized trimer of HIV gp140 having the amino acid sequence of SEQ ID NO: 5; and the one or more additional rAd26 vectors encode three HIV antigenic polypeptides having the amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 3 and SEQ ID NO: 4.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.225
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14863808', '15693650', '15380123', '14632433', '14149549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7251194915249146
- 35 USC 102 Novelty (BERT): 0.6659783977828848
- Combined Prediction Score: 0.7192053821507116
- Mean Citation Score: 489.17223600000005
- Max Citation Score: 746.9863
- Similarity Product: 597.3356636569857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test